⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

June 30, 2026Neuropathology and Applied Neurobiology

Diagnostic Alteration Is Not Therapeutic Dependency: Lessons From Failed RET Inhibition in a PLAG‐Altered CNS Embryonal Tumour

Stjepan Škudar

View at Publisher

Ask AI

Bookmark

Share

Key Points

This research explores the distinction between diagnostic alterations and therapeutic dependency in the context of RET inhibition in CNS embryonal tumours.
Analysis of RET inhibition efficacy in PLAG-altered CNS embryonal tumours.
Evaluation of therapeutic implications based on the findings.
No datasets were generated or analyzed, indicating that no significant results were reported.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Implication

Analysis of diagnostic changes and therapeutic effects in PLAG-altered CNS embryonal tumours, highlighting implications for RET inhibition.

Abstract

No abstract yet. The journal hasn't published one we can show.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Stjepan Škudar (2026) studied this question.

synapsesocial.com/papers/6a4601a99ed1343031311809 https://doi.org/10.1111/nan.70088

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1CNS Embryonal Tumour With PLAG Family Gene Alteration: Failure of Response to RET InhibitionOriginal Research · 2026 · 3 citations
2Metabolic Reprogramming and Extracranial Solid Tumor Evolution in Infants2024
3RET Gene Alterations in Clinical Practice: A Comprehensive Review and Database Update2025 · 6 citations
4Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in <i>RET</i> -Altered Solid Tumors: Analysis of the RETgistry Global ConsortiumOriginal Research · 2026 · 4 citations
5Abstract LB389: Highly potent and selective RET inhibitor with robust anti-tumor activities against wild-type and acquired drug-resistant mutations2024

Redifferentiation with selpercatinib in radioactive iodine-refractory differentiated thyroid carcinoma harboring RET fusions: A mini review and case report2026
387 Pathogenicity of a CCDC6-RET Fusion in Malignant Peripheral Nerve Sheath Tumor (MPNST)2024
Adaptive Darwinian off-target resistance mechanisms to selective RET inhibition in RET driven cancer2024
Hypothalamic Neurochemical and Microglial Suppression in Long‐Standing Human Hibernation‐Like SyndromeNeuropathology and Applied Neurobiology · 2026
New Observations on a Low‐Grade Diffusely Infiltrative Tumour, SMARCB1 Mutant, Arguing for a New Tumour TypeNeuropathology and Applied Neurobiology · 2026

More from Neuropathology and Applied Neurobiology

More from DOBA Business School